CHINA PHARMA HOLDINGS, INC. Earnings Per Share, Basic and Diluted
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Earnings Per Share, Basic and Diluted of -$0.07 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-30
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.02.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.02.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.02.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.02.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.07.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.07.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.48.
- CHINA PHARMA HOLDINGS, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.25.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.04 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.06 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.07 10-K · filed 2022-03-30 |
| 2021-09-30 | -$0.02 10-Q · filed 2021-11-12 | -$0.04 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.05 10-Q · filed 2021-11-12 | -$0.08 derived: net income ÷ weighted average shares · filed 2022-11-14 |
| 2021-06-30 | -$0.02 10-Q · filed 2021-08-13 | -$0.03 10-Q · filed 2021-08-13 | -$0.06 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.09 derived: net income ÷ weighted average shares · filed 2022-11-14 |
| 2021-03-31 | -$0.02 10-Q · filed 2021-05-14 | -$0.04 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.07 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.07 derived: net income ÷ weighted average shares · filed 2022-11-14 |
| 2020-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2022-03-30 | -$0.05 derived: net income ÷ weighted average shares · filed 2022-03-30 | -$0.05 derived: net income ÷ weighted average shares · filed 2022-03-30 | -$0.07 10-K · filed 2022-03-30 |
| 2020-09-30 | -$0.02 10-Q · filed 2021-11-12 | -$0.02 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.04 10-Q · filed 2021-11-12 | -$0.47 derived: net income ÷ weighted average shares · filed 2021-11-12 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-13 | -$0.01 10-Q · filed 2021-08-13 | -$0.45 derived: net income ÷ weighted average shares · filed 2021-08-13 | -$0.46 derived: net income ÷ weighted average shares · filed 2021-08-13 |
| 2020-03-31 | -$0.02 10-Q · filed 2021-05-14 | -$0.45 derived: net income ÷ weighted average shares · filed 2021-05-14 | -$0.46 derived: net income ÷ weighted average shares · filed 2021-05-14 | -$0.48 derived: net income ÷ weighted average shares · filed 2021-05-14 |
| 2019-12-31 | -$0.43 derived: net income ÷ weighted average shares · filed 2021-03-26 | -$0.45 derived: net income ÷ weighted average shares · filed 2021-03-26 | -$0.47 derived: net income ÷ weighted average shares · filed 2021-03-26 | -$0.48 10-K · filed 2021-03-26 |
| 2019-09-30 | -$0.02 10-Q · filed 2020-11-13 | -$0.04 derived: net income ÷ weighted average shares · filed 2020-11-13 | -$0.04 10-Q · filed 2020-11-13 | -$0.22 derived: net income ÷ weighted average shares · filed 2020-11-13 |
| 2019-06-30 | -$0.02 10-Q · filed 2020-08-13 | -$0.03 10-Q · filed 2020-08-13 | -$0.20 derived: net income ÷ weighted average shares · filed 2020-11-13 | -$0.25 derived: net income ÷ weighted average shares · filed 2020-11-13 |
| 2019-03-31 | -$0.01 10-Q · filed 2020-05-14 | -$0.18 derived: net income ÷ weighted average shares · filed 2020-11-13 | -$0.23 derived: net income ÷ weighted average shares · filed 2020-11-13 | -$0.25 derived: net income ÷ weighted average shares · filed 2020-11-13 |
| 2018-12-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.22 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.24 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.25 10-K · filed 2020-03-30 |
| 2018-09-30 | -$0.04 10-Q · filed 2019-11-14 | -$0.07 derived: net income ÷ weighted average shares · filed 2019-11-14 | -$0.07 10-Q · filed 2019-11-14 | -$0.39 derived: net income ÷ weighted average shares · filed 2019-11-14 |
| 2018-06-30 | -$0.02 10-Q · filed 2019-08-14 | -$0.03 10-Q · filed 2019-08-14 | -$0.35 derived: net income ÷ weighted average shares · filed 2019-08-14 | -$0.40 derived: net income ÷ weighted average shares · filed 2019-08-14 |
| 2018-03-31 | -$0.01 10-Q · filed 2019-05-14 | -$0.32 derived: net income ÷ weighted average shares · filed 2019-05-14 | -$0.37 derived: net income ÷ weighted average shares · filed 2019-05-14 | -$0.43 derived: net income ÷ weighted average shares · filed 2019-05-14 |
| 2017-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2019-03-28 | -$0.37 derived: net income ÷ weighted average shares · filed 2019-03-28 | -$0.42 derived: net income ÷ weighted average shares · filed 2019-03-28 | -$0.44 10-K · filed 2019-03-28 |
| 2017-09-30 | -$0.05 10-Q · filed 2018-11-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2018-11-14 | -$0.13 10-Q · filed 2018-11-14 | -$0.20 derived: net income ÷ weighted average shares · filed 2018-11-14 |
| 2017-06-30 | -$0.05 10-Q · filed 2018-08-14 | -$0.07 10-Q · filed 2018-08-14 | -$0.15 derived: net income ÷ weighted average shares · filed 2018-08-14 | -$0.19 derived: net income ÷ weighted average shares · filed 2018-08-14 |
| 2017-03-31 | -$0.02 10-Q · filed 2018-05-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2018-05-14 | -$0.14 derived: net income ÷ weighted average shares · filed 2018-05-14 | -$0.20 derived: net income ÷ weighted average shares · filed 2018-05-14 |
| 2016-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$0.12 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$0.18 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$0.21 10-K · filed 2018-04-02 |
| 2016-09-30 | -$0.04 10-Q · filed 2017-11-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2017-11-14 | -$0.13 10-Q · filed 2017-11-14 | |
| 2016-06-30 | -$0.06 10-Q · filed 2017-08-14 | -$0.09 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | -$0.04 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | -$0.35 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |